Asciminib Prospective Non Interventional Study as 3rd Line Therapy or More to Treat Adult Patients With CML- CP in Real World Setting in France
Clinical trial NCT06092879 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06092879
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-03-06
- Primary completion
- 2026-12-15
- Enrollment
- 201
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.